Ajinomoto
A Japanese multinational food and biotechnology group best known for AJI-NO-MOTO monosodium glutamate, seasonings, processed foods, amino acids, nutrition, and biopharmaceutical services.
Last updated August 31, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Ajinomoto is a Japanese multinational food and biotechnology group whose name is inseparable from the history of umami seasoning. The business grew from Kikunae Ikeda’s early twentieth-century research into the distinctive savory taste of kombu broth. In 1908, Ikeda identified glutamate as the principal source of that taste, named it umami, and developed a method for producing a usable seasoning based on monosodium glutamate (MSG). The product was introduced under the trade name AJI-NO-MOTO in 1909, creating one of the earliest mass-market products built around a scientific understanding of taste. The original seasoning established Ajinomoto’s consumer identity, but the company progressively developed a much broader portfolio. Its food businesses include MSG and other umami seasonings, blended seasonings, soup stocks, cooking sauces, oils, processed and frozen foods, beverages, sweeteners, coffee products, and powdered drinks. Major consumer-facing lines include AJI-NO-MOTO seasoning, HON-DASHI soup stock, and Cook Do cooking products. Product formulations, names, and distribution channels vary by country: in Asian and Latin American markets the brand has often been sold directly to households, while in North America and Europe Ajinomoto has also supplied food manufacturers and industrial customers. Ajinomoto’s second major identity is as a fermentation, amino-acid, nutrition, and biotechnology company. The group has supplied amino acids for food, animal nutrition, pharmaceutical, clinical nutrition, and specialty-chemical applications. Its health-related activities have included clinical nutrition and pharmaceutical research, while its biotechnology operations have expanded into contract development and manufacturing for biopharmaceutical companies. This combination of consumer foods and applied bioscience distinguishes Ajinomoto from a conventional seasoning brand. International expansion began early, with overseas offices and exports established during the 1910s and 1920s. Production was later localized in markets including Southeast Asia, Latin America, and other regions, helping reduce shipping costs and adapt products to local cuisines. After the Second World War, the company resumed seasoning production and diversified through alliances, joint ventures, acquisitions, and locally developed products. It later restructured to concentrate more strongly on food and biomedical businesses, while divesting selected beverage, sweetener, food, and animal-nutrition assets. In the twenty-first century, Ajinomoto has combined consumer-food growth with sustainability, nutrition, and biopharmaceutical strategies. Its activities have included frozen-food acquisitions, formation of Ajinomoto Bio-Pharma Services, renewable-energy commitments, nutrition profiling, partnerships concerning microbial protein and emissions reduction, and the acquisition of Forge Biologics. The corporate brand therefore covers both familiar kitchen products and less visible business-to-business technologies. Ajinomoto remains active internationally, with umami, fermentation expertise, amino acids, and food technology at the center of its positioning.
History
Ajinomoto’s origins lie in the collaboration between chemist Kikunae Ikeda and the Suzuki business. Ikeda’s 1908 research into kombu broth identified glutamate as the basis of a savory taste different from the four tastes then commonly recognized. He called the sensation umami and patented a process for producing a practical seasoning. The product was presented in Tokyo in April 1909 under the name AJI-NO-MOTO and entered commercial sale the following month. Early marketing targeted household cooks, particularly through imagery and advertising directed at housewives. Production increased during the 1910s, and the company opened a Kawasaki factory in 1914. Overseas offices in New York and Shanghai followed in 1917 and 1918, with further distribution offices in Singapore, Hong Kong, and Taiwan during the 1920s. Ajinomoto’s export business grew substantially, although wartime controls and Japan’s increasing isolation later reduced production. Manufacturing of the seasoning stopped by 1944 during the Second World War. The company changed its name to Ajinomoto Co., Ltd. in 1946 and resumed seasoning production in 1947. Postwar sales recovered after controls were lifted, and the business expanded beyond MSG into nucleic-acid seasonings, processed foods, amino acids, pharmaceuticals, and specialty chemicals. Alliances with international food companies in the 1960s supported Japanese distribution of products such as cornflakes and soup, while local production of AJI-NO-MOTO expanded through Asia and Latin America. Fermentation feedstocks also evolved, including the later use of sugar-cane-derived amino acids, enabling production closer to overseas markets. Diversification accelerated in the 1970s. Ajinomoto introduced HON-DASHI in 1970, entered frozen foods in 1972, established an instant-coffee joint venture with General Foods in 1973, and launched Cook Do in 1978. The company also developed pharmaceutical amino acids, clinical nutrition, feed amino acids, and related technologies. During the 1980s and 1990s it increased overseas production and strengthened its amino-acid and biomedical activities. Products and research included clinical nutrition, liver-disease treatment, cancer-related work, sports supplements, and the sweetener aspartame. From the 2000s onward, Ajinomoto used acquisitions, joint ventures, and restructuring to reinforce food, frozen-food, nutrition, and biomedical businesses. It acquired or partnered with companies in condiments, sweeteners, contract biopharmaceutical manufacturing, frozen foods, and supplements. Some units were later sold or divested, including beverage, sweetener, food, and animal-nutrition assets, as the group narrowed its strategic focus. Ajinomoto Bio-Pharma Services was formed in 2018 through the combination of Ajinomoto Althea and OmniChem. Recent strategy has combined growth with environmental and nutrition objectives. The group introduced a global brand logo in 2017, developed a nutrient-profiling system for products, joined RE100, participated in WIPO GREEN, and registered a nutrition commitment at the Tokyo Nutrition Summit. It has also pursued partnerships involving microbial protein, agricultural restoration, and dairy-supply-chain emissions. Ajinomoto today operates as both a recognizable consumer brand and a diversified corporate platform built on food science, fermentation, amino acids, nutrition, and biotechnology.
- 2024
Electric-seasoning concept developed
[1]Joint research with Ochanomizu University produced a concept for changing perceived taste through transdermal electrical stimulation.
- 2023
Forge Biologics acquisition announced
[1]Ajinomoto acquired Forge Biologics to strengthen gene-therapy manufacturing and development capabilities.
- 2020
Nutrient profiling and renewable-energy initiatives expand
[1]Ajinomoto introduced a group nutrient-profiling system across selected markets and joined RE100.
- 2018
Ajinomoto Bio-Pharma Services formed
[1]Ajinomoto Althea and OmniChem were combined to create a broader biopharmaceutical services platform.
- 2017
Global Brand Logo introduced
[1]The group introduced a global logo intended to unify its corporate identity internationally.
- 2009
Centennial product release
[1]Ajinomoto released a product named Ajinomoto to mark the centenary of its founding.
- 2003
VONO brand introduced in Asian joint-venture markets
[1]Following an agreement with Unilever, Ajinomoto introduced VONO as part of a broader effort to build its own brand identity in selected markets.
- 1978
Cook Do launches
[1]Ajinomoto introduced the Cook Do line of Chinese-cuisine seasonings and cooking aids.
- 1972
Frozen-food business begins
[1]Ajinomoto entered frozen foods as part of its consumer-food diversification.
- 1970
HON-DASHI launches
[1]The company introduced its bonito-flavored instant dashi seasoning in Japan.
Products and positioning
An international food-science and biotechnology group combining everyday flavor enhancement with fermentation, amino-acid, nutrition, and biopharmaceutical expertise.
MSG and umami seasoning · 1909
AJI-NO-MOTO seasoning
Ajinomoto’s founding consumer product is a monosodium-glutamate seasoning used to intensify savory flavor. It remains the brand’s most recognizable offering, although formulations, packaging, and routes to market differ across countries. The product is sold to households in many Asian and Latin American markets and also has industrial applications in food manufacturing.
Soup stock and dashi seasoning · 1970
HON-DASHI
HON-DASHI is a convenient Japanese soup-stock product launched originally with bonito flavor. It extends Ajinomoto’s umami expertise into preparation of soups, broths, sauces, and everyday Japanese dishes, and has been adapted to local preferences in some overseas markets.
Blended seasonings and cooking aids · 1978
Cook Do
Cook Do is a line of prepared seasoning bases and cooking aids intended to simplify home preparation of Chinese and other dishes. It reduces the need to assemble multiple ingredients while retaining a connection to Ajinomoto’s flavor-development expertise.
Sports and nutritional supplement · 1995
Amino Vital
Amino Vital is an amino-acid-oriented supplement line associated with sports nutrition and active lifestyles. It reflects Ajinomoto’s extension from culinary seasonings into consumer health and nutrition products.
Food, nutrition, pharmaceutical, and biotechnology inputs · 1956
Amino acids
Amino acids are a core business-to-business technology platform for Ajinomoto. Products and processes serve food, animal nutrition, pharmaceutical, clinical nutrition, and specialty-chemical applications, linking the group’s fermentation expertise with industrial and health-related markets.
Biopharmaceutical contract development and manufacturing · 2018
Ajinomoto Bio-Pharma Services
Ajinomoto Bio-Pharma Services provides development and manufacturing capabilities for biopharmaceutical customers. It was created through the combination of Ajinomoto Althea and OmniChem and represents the group’s corporate expansion into specialized biomedical services.
Brand decisions
2024
Strategic partnership with Danone on emissions reductionOtherBackground
Food companies face pressure to reduce emissions in agricultural and dairy supply chains.
Action taken
Ajinomoto entered a global strategic partnership with Danone to reduce greenhouse-gas emissions from Danone’s raw-milk supply chain.
Aftermath
The partnership extended Ajinomoto’s sustainability activity beyond its own manufacturing footprint into supply-chain collaboration.
2023
Forge Biologics acquisitionM&ABackground
Ajinomoto sought to expand its biopharmaceutical development and manufacturing platform, particularly in advanced therapies.
Action taken
The group acquired United States-based Forge Biologics.
Aftermath
The transaction strengthened Ajinomoto’s presence in gene-therapy-related contract development and manufacturing.
Reported acquisition value. US$620 million (November 2023)
2017
Adoption of a global brand identityStrategyBackground
Ajinomoto operated through a diverse international group with varying local brands and businesses.
Action taken
The group introduced a Global Brand Logo for broader use across Ajinomoto operations.
Aftermath
The initiative supported a more consistent corporate presentation while local product portfolios continued to differ by market.
2010
Restructuring toward food and biomedical prioritiesStrategyBackground
Increasing foreign competition and the breadth of the group’s portfolio prompted Ajinomoto to review its diversification strategy.
Action taken
The group began concentrating on selected food and biomedical businesses while divesting or reducing emphasis on other activities.
Aftermath
Subsequent actions included the disposal of beverage, sweetener, food, and animal-nutrition operations and acquisitions in frozen foods, supplements, and biopharmaceutical services.
Recent events
Ajinomoto's aminostep lifestyle app launches[3]
Reported:
Ajinomoto launched the aminostep app in April. It enables users to store AminoIndex test results and provides personalized diet and physical-activity advice; it also includes a paid online health consultation service that rolled out in May.
BlueCat DNS deployment on Ajinomoto’s hybrid cloud network[4]
Reported:
BlueCat announced that its DNS service points were in the process of being deployed into Ajinomoto’s hybrid cloud network.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/ajinomoto · Editorial policy · How profiles are compiled